HYDE-SMITH WELCOMES FDA APPROVAL OF FIRST GENERIC OF RESTASIS
HYDE-SMITH WELCOMES FDA APPROVAL OF FIRST GENERIC OF RESTASIS
Miss. Senator Long Critical of Company behind Skyrocketing Cost of Prescription Eye-Drop Medication
WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.) today welcomed approval by the Food and Drug Administration (FDA) of a generic alternative to the eye-drop prescription drug Restasis, a decision she has long...